Daily News
Report Reveals Surprises Leading to First IVF Baby
Saturday, July 24, 2010 07:05 PM(MedPage Today) -- The U.K. Medical Research Council's decision not to support Robert Edwards' and Patrick Steptoe's research on in vitro fertilization in the early 1970s was considerably more thoughtful than the story most people know, according to a review of government and other archives.
Thyroid Provides Clues to Placental Abruption (CME/CE)
Saturday, July 24, 2010 12:00 PM(MedPage Today) -- Pregnant women with higher levels of certain thyroid autoantibodies have an increased likelihood of developing placental abruption, researchers found.
Bones May Hold Key to New Diabetes Drugs (CME/CE)
Friday, July 23, 2010 10:00 AM(MedPage Today) -- Bone cell responses to insulin may control how the rest of the body responds, studies in mice suggest.
Endocrinologist Reflects on Rosiglitazone
Thursday, July 22, 2010 07:12 PMWASHINGTON (MedPage Today) -- As the FDA processes the vote and discussion from last week's advisory committee meeting on rosiglitazone (Avandia), an endocrinologist who has twice voted to keep the diabetes drug on the market dissected what the recent vote means in a perspective published in the New England Journal of Medicine.
FDA Orders Enrollment Freeze on Rosiglitazone Trial
Wednesday, July 21, 2010 02:49 PMWASHINGTON (MedPage Today) -- The FDA has ordered GlaxoSmithKline, the maker of rosiglitazone (Avandia), to stop enrolling patients in its ongoing head-to-head outcomes trial comparing the drug with pioglitazone (Actos).
Model May Aid Decisions After Failed IVF (CME/CE, with audio)
Monday, July 19, 2010 03:00 PM(MedPage Today) -- A clinical model for in vitro fertilization (IVF) significantly improved the accuracy for predicting live births after unsuccessful IVF compared with conventional criteria based on maternal age, results of a validation study showed.
IVF Kids May Have Higher Cancer Risk (CME/CE)
Monday, July 19, 2010 09:32 AM(MedPage Today) -- Children conceived using in vitro fertilization (IVF) appear to have a moderately elevated risk of cancer -- although the absolute risk remains low -- according to a large population-based study from Sweden.
Rosiglitazone Hearing Reveals Not-So-Rosy Rifts at FDA
Friday, July 16, 2010 05:10 PM(MedPage Today) -- This week's FDA advisory committee meeting on rosiglitazone (Avandia) drew back the curtain on the agency's internal politics but left its final decision shrouded in uncertainty.
First-Void Urine Predicts Renal Events (CME/CE)
Friday, July 16, 2010 10:02 AM(MedPage Today) -- The albumin:creatinine ratio from a first-void urine sample significantly outperformed other parameters for predicting future renal events in patients with diabetic nephropathy, investigators in a multinational study concluded.
Keep Rosiglitazone on the Market, FDA Panel Says
Wednesday, July 14, 2010 07:00 PM(MedPage Today) -- GAITHERSBURG, Md. -- An advisory panel voted 20-12 to recommend that the FDA allow rosiglitazone (Avandia) to stay on the market, but most panelists want to see the controversial diabetes drug carry tougher warnings on its label.
Diabetic Supplies from Support Plus Medical
You could be eligible to receive the testing supplies you need, the easy way, for little or no out-of-pocket cost.* Support Plus Medical is the supplies division of American Diabetes.
Find out if you qualify today with a free and simple profile: Free Diabetic Supplies Form
* Deductibles and co-pays may apply.